HB217 Alabama 2011 Session

Summary

Primary Sponsor

Mike Millican

Republican

Session

Regular Session 2011

Title

Medicaid Agency, generic prescription drugs, competitive bid process to establish low price from manufacturers, Medicaid Generic Drug Competition and Savings Act

Summary

HB217 would require Alabama's Medicaid Agency to use a competitive bid process to obtain generic drugs at the lowest possible price for Medicaid recipients.

What This Bill Does

The bill creates a transparent bidding system for generic drug manufacturers to compete for contracts with Medicaid. It requires all generic manufacturers serving Medicaid to participate in this bidding to secure low-cost purchases while maintaining quality. It also repeals laws that conflict with this act and sets an effective date for when the rules take effect.

Who It Affects

• Medicaid recipients in Alabama, who would receive generic drugs at lower, competitively bid prices.
• Generic drug manufacturers that supply or plan to supply drugs to Alabama Medicaid, who would be required to compete in the bid process.

Key Provisions

• The act is titled 'The Medicaid Generic Drug Competition and Savings Act.'
• Defines key terms: competitive bid process, generic drugs, generic manufacturers, and Medicaid for clarity in implementation.
• Requires the State Medicaid Agency to establish and use a competitive bid process to obtain generic drugs for Medicaid at the lowest possible cost.
• Requires all generic drug manufacturers providing products to Medicaid recipients to participate in the competitive bid process.
• Repeals any laws or parts of laws that conflict with this act.
• Effective date: the act takes effect on the first day of the third month after it is passed and approved by the Governor.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Health